右侧心力衰竭的评估与管理:美国心脏协会科学声明
该科学声明由美国心脏协会撰写,基于系统文献综述总结右心衰竭的病因、流行病学、病理生理及管理建议。慢性右心衰竭与运动耐量下降、心输出量减少及终末器官损伤相关,是肺动脉高压患者的主要死因;急性右心衰竭与血流动力学不稳定相关,是大面积肺栓塞、右室心肌梗死及心脏术后休克的主要死因。针对孤立性急慢性右心衰竭的药物和机械干预研究不足,缺乏促进右室功能稳定和恢复的特异性治疗。
要点
- 慢性右心衰竭与运动耐量下降、心输出量减少、终末器官损伤和恶病质相关,是肺动脉高压患者的主要死因。
- 急性右心衰竭与血流动力学不稳定相关,是大面积肺栓塞、右室心肌梗死和心脏术后休克的主要死因。
- 针对孤立性急慢性右心衰竭的药物和机械干预研究不足,缺乏促进右室功能稳定和恢复的特异性治疗。
核心结论
- 右心衰竭是包含多样病因、通路和病理过程的复杂综合征。
- 该声明综述了右室功能障碍的病因和流行病学以及急慢性右心衰竭的病理生理,并为相关情况的管理提供指导。
研究设计与样本
- 写作组通过系统文献综述、已发表的转化和临床研究、临床实践指南及专家意见/声明总结现有证据。
- 检索MEDLINE、EMBASE和Web of Science截至2017年9月的成人医学文献,排除常规实验室检查。
主要发现
- 慢性右心衰竭与运动耐量下降、功能容量差、心输出量减少和终末器官损伤相关。
- 终末器官损伤由静脉淤血和灌注不足共同导致,恶病质源于营养吸收不良和全身促炎状态。
- 慢性右心衰竭是肺动脉高压患者的主要死因。
- 急性右心衰竭与血流动力学不稳定相关,是大面积肺栓塞、右室心肌梗死和心脏术后休克的主要死因。
- 右心功能评估可能因其复杂几何形态而受限,多种血流动力学和生化标志物与右心衰竭恶化相关。
临床怎么用
- 多种血流动力学和生化标志物可指导临床评估和治疗决策。
- 针对孤立性急慢性右心衰竭的药物和机械干预研究不足,缺乏促进右室功能稳定和恢复的特异性治疗。
局限性
- 针对孤立性急慢性右心衰竭的药物和机械干预尚未得到充分研究。
- 缺乏促进右室功能稳定和恢复的特异性治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: The diverse causes of right-sided heart failure (RHF) include, among others, primary cardiomyopathies with right ventricular (RV) involvement, RV ischemia and infarction, volume loading caused by cardiac lesions associated with congenital heart disease and valvular pathologies, and pressure loading resulting from pulmonic stenosis or pulmonary hypertension from a variety of causes, including left-sided heart disease. Progressive RV dysfunction in these disease states is associated with increased morbidity and mortality. The purpose of this scientific statement is to provide guidance on the assessment and management of RHF. METHODS: The writing group used systematic literature reviews, published translational and clinical studies, clinical practice guidelines, and expert opinion/statements to summarize existing evidence and to identify areas of inadequacy requiring future research. The panel reviewed the most relevant adult medical literature excluding routine laboratory tests using MEDLINE, EMBASE, and Web of Science through September 2017. The document is organized and classified according to the American Heart Association to provide specific suggestions, considerations, or reference to contemporary clinical practice recommendations. RESULTS: Chronic RHF is associated with decreased exercise tolerance, poor functional capacity, decreased cardiac output and progressive end-organ damage (caused by a combination of end-organ venous congestion and underperfusion), and cachexia resulting from poor absorption of nutrients, as well as a systemic proinflammatory state. It is the principal cause of death in patients with pulmonary arterial hypertension. Similarly, acute RHF is associated with hemodynamic instability and is the primary cause of death in patients presenting with massive pulmonary embolism, RV myocardial infarction, and postcardiotomy shock associated with cardiac surgery. Functional assessment of the right side of the heart can be hindered by its complex geometry. Multiple hemodynamic and biochemical markers are associated with worsening RHF and can serve to guide clinical assessment and therapeutic decision making. Pharmacological and mechanical interventions targeting isolated acute and chronic RHF have not been well investigated. Specific therapies promoting stabilization and recovery of RV function are lacking. CONCLUSIONS: RHF is a complex syndrome including diverse causes, pathways, and pathological processes. In this scientific statement, we review the causes and epidemiology of RV dysfunction and the pathophysiology of acute and chronic RHF and provide guidance for the management of the associated conditions leading to and caused by RHF.
引用
- Konstam MA, Kiernan MS, Bernstein D, et al. Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association. Circulation. 2018. PMID: 29650544. doi:10.1161/CIR.0000000000000560
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。